Select Page


The IBB(iShares Nasdaq Biotechnology Index)is surging over 3.5% today.  This powerful breakout move, which is the indexes best gain of 2018, has driven it past the June and February highs.  The IBB is setting up well for a retest of the 2018 peak($119.30).  Here’s a look at the top ten weightings in this Biotech ETF:

  • Gilead Sciences, Inc. 8.27%
  • Amgen Inc. 8.09%
  • Biogen Inc. 7.77%
  • Celgene Corporation 7.34%
  • Illumina, Inc. 5.24%
  • Regeneron Pharmaceuticals, Inc. 4.52%
  • Vertex Pharmaceuticals Incorporated 4.34%
  • Alexion Pharmaceuticals, Inc. 3.60%g

 At time of posting we are long IBB in some managed accounts.